BALM3 Stock Overview

Engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. More details

BALM3 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	6/6
Dividends	1/6

Rewards

Trading at 73.3% below our estimate of its fair value

Became profitable this year

Risk Analysis

Earnings have declined by 4.7% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap (R$117M)

My Notes

Capture your thoughts, links and company narrative

Baumer S.A. Competitors

Sincere

TSE:7782

JP¥3.1b

GSM Foils

NSEI:GSMFOILS

₹1.5b

Profarma Distribuidora de Produtos Farmacêuticos

BOVESPA:PFRM3

R$795.7m

EPS Bio Technology

TPEX:4183

NT$537.9m

Price History & Performance

Summary of share price highs, lows and changes for Baumer
Historical stock prices
Current Share Price	R$13.00
52 Week High	R$19.00
52 Week Low	R$9.90
Beta	0.41
1 Month Change	0%
3 Month Change	-19.75%
1 Year Change	n/a
3 Year Change	-16.13%
5 Year Change	13.04%
Change since IPO	418.96%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	BALM3	BR Medical Equipment	BR Market
7D	0%	-1.4%	-1.1%
1Y	n/a	7.2%	-14.1%

Return vs Industry: Insufficient data to determine how BALM3 performed against the BR Medical Equipment industry.

Return vs Market: Insufficient data to determine how BALM3 performed against the BR Market.

Price Volatility

Is BALM3's price volatile compared to industry and market?
BALM3 volatility
BALM3 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.8%
Market Average Movement	5.1%
10% most volatile stocks in BR Market	9.7%
10% least volatile stocks in BR Market	3.0%

Stable Share Price: BALM3's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine BALM3's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1952	n/a	Ruy Salvari Baumer	www.baumer.com.br

Baumer S.A. engages in the development, industrialization, trade, production, import, export, and technical assistance in products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil. The company offers drugs for bone regeneration, including membrane and graft; and equipment for safe environment, disinfection, preparing and inspecting, water treatment, sterilization, transfer, storage, transport, surgical room, and cleaning. It also provides orthopedic devices, such as conventional prosthesis, non-conventional prosthesis, trauma, neurosurgery, and bone cement.

Baumer S.A. Fundamentals Summary

How do Baumer's earnings and revenue compare to its market cap?
BALM3 fundamental statistics
Market cap	R$117.41m
Earnings (TTM)	R$9.57m
Revenue (TTM)	R$178.51m

11.3x

P/E Ratio

0.6x

P/S Ratio

Is BALM3 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BALM3 income statement (TTM)
Revenue	R$178.51m
Cost of Revenue	R$68.92m
Gross Profit	R$109.59m
Other Expenses	R$100.03m
Earnings	R$9.57m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.98
Gross Margin	61.39%
Net Profit Margin	5.36%
Debt/Equity Ratio	10.7%

How did BALM3 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

-126%

Payout Ratio

Does BALM3 pay a reliable dividends?

See BALM3 dividend history and benchmarks

When do you need to buy BALM3 by to receive an upcoming dividend?
Baumer dividend dates
Ex Dividend Date	Dec 20 2024
Dividend Pay Date	Feb 27 2025
Days until Ex dividend	14 days
Days until Dividend pay date	55 days

Does BALM3 pay a reliable dividends?

See BALM3 dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/02 03:31
End of Day Share Price	2024/12/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Baumer S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution